About MSBiotec
MSBiotec is an Agriculture company based in Wamego (United States) founded in 2005. MSBiotec has raised $60.99 million across 2 funding rounds from investors including Paine Schwartz Partners. Its chief executive, as recorded, is Leander Walt. MSBiotec offers products and services including Multimin 90 and Lactipro. Its focus areas include Food and Agriculture Tech, Livestock Tech, Health Management and Nutrition Supplements. Its competitors include Native Microbials, Menon and Bentoli; 2 of its 3 listed competitors have raised funding.
Company details
Manufacturer and distributor of biological farm inputs for cattle. It offers a natural feed supplement for ruminant animals. The company claims to produce the product using a robust strain of a lactic acid-utilizing bacteria which acts as an oral drench for cattle at the time of transition from low- to high-concentrate diets.
- Headquarters Wamego, United States
- SectorsAgriculture
- Email••••••••
- Phone•••• ••••
- Website msbiotec.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$60.99M (USD)
in 2 rounds
- Latest Funding Round$59.08M (USD), Series B
Oct 2018
- Investors
Products & Services of MSBiotec
MSBiotec offers a comprehensive portfolio of products and services, including Multimin 90 and Lactipro.
Provides essential minerals to support cattle health and reproduction.
Enhances lactic acid utilization in cattle for better digestion.
Funding Insights of MSBiotec
MSBiotec has successfully raised a total of $60.99M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $59.08 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60.99M
- Total Rounds 2
- Last Round Series B — $59.08M
- First Round $1.9M
(Jan 2012)
- Investors Count 1
All 2 funding rounds of MSBiotec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2018 | $59.08M | Series B | – | Paine Schwartz Partners | – |
| Jan 2012 | $1.9M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in MSBiotec
MSBiotec has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Paine Schwartz Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm focused on food and agribusiness sectors | paineschwartz.com | New York, United States |
Investor details for MSBiotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MSBiotec
9 people are tracked at MSBiotec (1 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Leander Walt | CEO | Leadership |
Samantha Z. | Financial Planning And Analysis Manager | Team |
Michelle Coleman | Laboratory Specialist | Team |
Cody Rottinghaus | Operations Manager | Team |
Minh Pham | Supply Chain Intern | Team |
Cassandra Hoffman | Quality Assurance Manager | Team |
John Isermann | Product & Distribution Manager | Team |
Michael McMurray | Facilities Manager | Team |
Amber Walz | Executive Assistant | Team |
Complete people profiles for MSBiotec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MSBiotec
3 dated milestones of MSBiotec across 13 years, from founding to its latest funding, stage changes and deals.
- Founded MSBiotec is founded.
- Funding First funding round of $1.9M.
- Funding Latest funding round, Series B, of $59.1M.
Competitors of MSBiotec
MSBiotec has 3 listed competitors in our database, 2 of them funded. They include Native Microbials, Menon and Bentoli.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nativemicrobials.com | 2015 | San Diego, United States | $69.69M | 32 | Microbial solutions for animals are developed using proprietary technologies. | |
| menon.us | 2000 | San Diego, United States | $3M | Conversion of agriculture byproducts into animal feedstock and development of biosensors for pathogen detection | ||
| bentoli.com | 1971 | Austin, United States | 112 | Global manufacturer of animal feed additives for swine, poultry, and other livestock species. |
Detailed competitors of MSBiotec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Msbiotec
Complete news archive for MSBiotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSBiotec
MSBiotec was founded in 2005 and raised its 1st funding round 7 years after it was founded.
MSBiotec is headquartered in Wamego, United States. It is registered at Wamego, Kansas, United States.
Leander Walt is the CEO of MSBiotec, as recorded in our data.
MSBiotec is a funded company, having raised a total of $60.99M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.9M, raised on Jan 2012.
Manufacturer and distributor of biological farm inputs for cattle. It offers a natural feed supplement for ruminant animals. The company claims to produce the product using a robust strain of a lactic acid-utilizing bacteria which acts as an oral drench for cattle at the time of transition from low- to high-concentrate diets.
MSBiotec's top competitors include Native Microbials, Menon and Bentoli.
MSBiotec offers Multimin 90 and Lactipro.
MSBiotec has 1 investor. Key investors include Paine Schwartz Partners.